Trials / Completed
CompletedNCT02375633
Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 166 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Multicenter, Randomized, Double-blinded, Parallel, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DW-330SR2 | |
| DRUG | Pelubiprofen |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-11-01
- First posted
- 2015-03-02
- Last updated
- 2016-10-10
Source: ClinicalTrials.gov record NCT02375633. Inclusion in this directory is not an endorsement.